HCW Biologics Ownership | Who Owns HCW Biologics?


OverviewRevenueFinancialsChart

HCW Biologics Ownership Summary


HCW Biologics is owned by 1.95% institutional investors, 52.30% insiders, and 45.74% retail investors. Armistice capital is the largest institutional shareholder, holding 5.35% of HCWB shares. Fidelity Extended Market Index is the top mutual fund, with 0.20% of its assets in HCW Biologics shares.

HCWB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHCW Biologics1.95%52.30%45.74%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Armistice capital2.02M5.35%$902.76K
Avantax planning partners279.54K0.74%$124.70K
Geode capital management181.96K0.48%$81.20K
Hightower advisors180.81K0.48%$80.66K
Cresset asset management131.99K0.35%$58.88K
Pullen investment management85.12K0.23%$55.07K
Blackrock42.66K0.11%$27.60K
Blackrock funding, inc. /de42.99K0.11%$19.18K
Vanguard group37.68K0.10%$16.80K
Bridgeway capital management34.70K0.09%$15.48K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pullen investment management85.12K0.05%$55.07K
Armistice capital2.02M0.01%$902.76K
Avantax planning partners279.54K0.00%$124.70K
Xtx topco34.00K0.00%$15.17K
Virtu financial15.62K0.00%$7.00K
Cresset asset management131.99K0.00%$58.88K
Bridgeway capital management34.70K0.00%$15.48K
Ae wealth management30.00K0.00%$13.38K
Hightower advisors180.81K0.00%$80.66K
Two sigma investments, lp12.08K-$5.39K

Top Buyers

HolderShares% AssetsChange
Armistice capital2.02M0.01%2.02M
Xtx topco34.00K0.00%34.00K
Virtu financial15.62K0.00%15.62K
Renaissance15.00K-15.00K
Citadel advisors13.88K-13.88K

Top Sellers

HolderShares% AssetsChange
Bridgeway capital management34.70K0.00%-50.00K
Hrt financial lp---46.50K
Jane street group---24.14K
Two sigma investments, lp12.08K--10.36K
Ubs group---4.83K

New Positions

HolderShares% AssetsChangeValue
Armistice capital2.02M0.01%2.02M$902.76K
Xtx topco34.00K0.00%34.00K$15.17K
Virtu financial15.62K0.00%15.62K$7.00K
Renaissance15.00K-15.00K$6.69K

Sold Out

HolderChange
Jpmorgan chase-9.00
Wells fargo & company/mn-141.00
Ubs group-4.83K
Jane street group-24.14K
Hrt financial lp-46.50K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20246-62.50%738,597-36.28%120.79%1-75.00%2-50.00%
Sep 30, 202416-11.11%1,159,083-4.39%328.89%4-42.86%4-20.00%
Jun 30, 202418-5.26%1,212,33710.20%334.74%7-5-
Mar 31, 2024195.56%1,100,1103.30%334.85%7-36.36%566.67%
Dec 31, 20231828.57%1,064,9554.94%237.12%1183.33%350.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index91.84K0.20%-585.00
iShares Micro-Cap ETF38.80K0.09%-
Vanguard Institutional Extnd Mkt Idx Tr37.68K0.08%-
Bridgeway Ultra-Small Company Market34.70K0.08%-50.00K
Fidelity Total Market Index29.02K0.06%-
Fidelity Nasdaq Composite Index23.27K0.05%-
Fidelity Series Total Market Index21.30K0.05%-
Spartan Extended Market Index Pool F12.80K0.03%585.00
Spartan Extended Market Index Pool E12.80K0.03%585.00
Northern Trust Extended Eq Market Idx9.06K0.02%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 14, 2023Wong Hing C Chief Executive OfficerBuy$3.74K
Sep 14, 2023Winer Gary M-Buy$336.96
Sep 13, 2023Winer Gary M-Buy$92.00
Sep 13, 2023Winer Gary M-Buy$1.02K
Sep 14, 2023Winer Gary M-Buy$1.80K

Insider Transactions Trends


DateBuySell
2024 Q1--
2023 Q4--
2023 Q316-
2023 Q217-
2022 Q4--

HCWB Ownership FAQ


Who Owns HCW Biologics?

HCW Biologics shareholders are primarily institutional investors at 1.95%, followed by 52.30% insiders and 45.75% retail investors. The average institutional ownership in HCW Biologics's industry, Biotech Stocks , is 68.48%, which HCW Biologics falls below.

Who owns the most shares of HCW Biologics?

HCW Biologics’s largest shareholders are Armistice capital (2.02M shares, 5.35%), Avantax planning partners (279.54K shares, 0.74%), and Geode capital management (181.96K shares, 0.48%). Together, they hold 6.57% of HCW Biologics’s total shares outstanding.

Does Blackrock own HCW Biologics?

Yes, BlackRock owns 0.11% of HCW Biologics, totaling 42.66K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 27.6K$. In the last quarter, BlackRock decreased its holdings by -3.372K shares, a -7.33% change.

Who is HCW Biologics’s biggest shareholder by percentage of total assets invested?

Pullen investment management is HCW Biologics’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 85.12K HCW Biologics shares, valued at 55.07K$.

Who is the top mutual fund holder of HCW Biologics shares?

Fidelity Extended Market Index is the top mutual fund holder of HCW Biologics shares, with 0.20% of its total shares outstanding invested in 91.84K HCW Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools